HuagongsheHuagongshe Chemistry Print Report · For research reference only
Piperazine → 4-[1-(3,5-dibromo-4-hydroxy-benzoyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-7-yl]-benzonitrile
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | Lithium Bromide | HCID 82050 | — |
| Reactant | HCID 66936516 | HCID 66936516 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 4-[1-(3,5-dibromo-4-hydroxy-benzoyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-7-yl]-benzonitrile | HCID 44609035 | — |
Reaction Steps
By the same method as in the step d) of Example 45, 4-[1-(3,5-dibromo-4-methoxy-benzoyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-7-yl]-benzonitrile (116 mg, 0.22 mmol), lithium bromide (76 mg, 0.88 mmol) and piperazine (29 mg, 0.33 mmol) were dissolved in N,N-dimethyl formamide (3 ml) and reacted at 1000 to obtain the target compound 65, i.e., 4-[1-(3,5-dibromo-4-hydroxy-benzoyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-7-yl]-benzonitrile, as white solid (49 mg, 43%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08394792B2 |
| Source dataset | uspto-grants-2013_03 |
| ORD ID | ord-c6957c62d4e74ac5bee75e87acfa451f |
| Source note | uspto-grants-2013_03 |